SERIES · Foundations
The Body’s Tiny Signal System
Peptides are short chains of amino acids that carry instructions. GLP-1 is one of them, but the signal system is much bigger.
GLP peptides should be accessible.
The science, knowledge, and pricing.
Peptide Science /Explained
Understand how peptides work.
Read More: What Do Peptides Do? The Body’s Tiny Signal System
What comes after Ozempic
Catalystpeptide.
Studied for weight, metabolic and cardiovascular markers, and liver fat.
Targets three receptor pathways.
GLP-1regulates appetite and insulin.
GIPsupports glucose handling.
Glucagonsignals the body to use stored energy (fat).
What the science shows.
28.7%
Average Body Weight Loss
86%
Reduction in Liver Fat
41%
Reduction in Triglycerides
Figures reported in Phase 3 trials, among trial participants. Not a treatment claim for Catalyst products.
Peptide / News
Breakthroughs, clinical data, culture, policy, and industry.
The GLP Company We Wished Existed
Our Promise
At least 10% lowerprices by 2028.
A promise that goes further, the more of us there are.
What you should know.
Start with Science Explained for foundational guides, Peptide News for current developments, or the GLP-3 Overview for a focused introduction to the next generation of GLP research.
Science Explained is a library of visual, plain-language guides to peptide biology, GLP mechanisms, myths, and the questions readers ask most.
Peptide News follows the research, companies, policy decisions, and market developments shaping the peptide category.
The GLP-3 Overview is a focused introduction to triple-receptor research and how GLP-1, GIP, and glucagon pathways are studied together.
What comes after Ozempic
Catalyst /peptide.
Targets three receptor pathways.
GLP-1regulates appetite and insulin.
GIPsupports glucose handling.
Glucagonsignals the body to use stored energy (fat).
Phase 3 findings report changes in weight, liver fat, and lipid measures among trial participants. They are not a treatment claim for Catalyst products.
Figures reported in Phase 3 trials, among trial participants. Not a treatment claim for Catalyst products.
Studied for weight, metabolic and cardiovascular markers, and liver fat.
28.7%
Average Body Weight Loss
86%
Reduction in Liver Fat
41%
Reduction in Triglycerides
The GLP Company We Wished Existed
At least 10% lower
prices by
A promise that goes further,
the more of us there are.
What you should know.
Where should I start?
Start with Science Explained for foundational guides, Peptide News for current developments, or the GLP-3 Overview for a focused introduction to the next generation of GLP research.
What is Science Explained?
Science Explained is a library of visual, plain-language guides to peptide biology, GLP mechanisms, myths, and the questions readers ask most.
What is Peptide News?
Peptide News follows the research, companies, policy decisions, and market developments shaping the peptide category.
What is the GLP-3 Overview?
The GLP-3 Overview is a focused introduction to triple-receptor research and how GLP-1, GIP, and glucagon pathways are studied together.